Literature DB >> 26156839

Undetected supraventricular tachycardia causing congestive heart failure: a pitfall of remote monitoring system.

Keisuke Nakabayashi1, Ryo Sugiura1, Toshiaki Oka1.   

Abstract

Remote monitoring systems with automated clinician alerts are a milestone development for implantable cardiovascular devices, and improve the quality of life for patients and physicians by reducing the number of conventional clinic visits. In addition, remote monitoring systems can detect many bradyarrhythmias and tachyarrhythmias earlier than traditional methods, although these devices are not perfect. We report the case of an 80-year-old woman with an implanted pacemaker and a remote monitoring system that failed to report acute heart failure at 10 months after implantation. ECG and telemetry revealed relatively slow supraventricular tachycardia, which did not trigger the alert, and catheter ablation successfully controlled the heart failure. Subsequent analysis revealed that the monitoring function had detected the arrhythmia as frequent premature ventricular contraction, although the arrhythmia did not trigger the automated clinician alert. Therefore, remote monitoring systems with accurate settings are essential, although conventional monitoring methods are still important for some patients. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26156839      PMCID: PMC4499732          DOI: 10.1136/bcr-2015-210839

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Remote monitoring of cardiac implantable devices in the Asia-Pacific.

Authors:  Chu-Pak Lau; Shu Zhang
Journal:  Europace       Date:  2013-06       Impact factor: 5.214

2.  Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.

Authors:  Niraj Varma; Andrew E Epstein; Anand Irimpen; Robert Schweikert; Charles Love
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

3.  Management of alert messages in the remote monitoring of implantable cardioverter defibrillators and pacemakers: an Italian single-region study.

Authors:  Antonio Franco Folino; Francesco Chiusso; Gabriele Zanotto; Diego Vaccari; Gianni Gasparini; Antonella Megna; Elena Marras; Roberto Mantovan; Alessandro Vaglio; Gabriele Boscolo; Gianluca Biancalana; Loira Leoni; Sabino Iliceto; Gianfranco Buja
Journal:  Europace       Date:  2011-06-03       Impact factor: 5.214

4.  Socio-economic effects and cost saving potential of remote patient monitoring (SAVE-HM trial).

Authors:  S Perl; P Stiegler; B Rotman; G Prenner; P Lercher; M Anelli-Monti; M Sereinigg; V Riegelnik; E Kvas; C Kos; F R Heinzel; K H Tscheliessnigg; B Pieske
Journal:  Int J Cardiol       Date:  2013-11-30       Impact factor: 4.164

5.  The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts.

Authors:  George H Crossley; Andrew Boyle; Holly Vitense; Yanping Chang; R Hardwin Mead
Journal:  J Am Coll Cardiol       Date:  2011-01-20       Impact factor: 24.094

Review 6.  Home monitoring for heart failure management.

Authors:  Anh L Bui; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2012-01-10       Impact factor: 24.094

7.  Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers.

Authors:  George H Crossley; Jane Chen; Wassim Choucair; Todd J Cohen; Douglas C Gohn; W Ben Johnson; Eleanor E Kennedy; Luc R Mongeon; Gerald A Serwer; Hongyan Qiao; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

8.  Potential role of remote monitoring for scheduled and unscheduled evaluations of patients with an implantable defibrillator.

Authors:  Hein Heidbüchel; Pieter Lioen; Stefaan Foulon; Wim Huybrechts; Joris Ector; Rik Willems; Hugo Ector
Journal:  Europace       Date:  2008-02-01       Impact factor: 5.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.